Monarch Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.07M | Buy |
127,572
+2,730
| +2% | +$71.4K | 0.7% | 43 |
|
|
2026
Q1 | $3.51M | Sell |
124,842
-1,000
| -0.8% | -$26.6K | 0.86% | 39 |
|
|
2025
Q4 | $3.13M | Buy |
125,842
+4,297
| +4% | +$108K | 0.77% | 41 |
|
|
2025
Q3 | $3.1M | Buy |
121,545
+1,425
| +1% | +$35.2K | 0.76% | 40 |
|
|
2025
Q2 | $2.91M | Buy |
120,120
+4,340
| +4% | +$101K | 0.78% | 41 |
|
|
2025
Q1 | $2.93M | Buy |
115,780
+398
| +0.3% | +$10.4K | 0.82% | 40 |
|
|
2024
Q4 | $3.06M | Buy |
115,382
+8,152
| +8% | +$221K | 0.84% | 39 |
|
|
2024
Q3 | $3.1M | Buy |
107,230
+1,098
| +1% | +$32K | 0.84% | 40 |
|
|
2024
Q2 | $2.97M | Sell |
106,132
-2,094
| -2% | -$57.7K | 0.87% | 37 |
|
|
2024
Q1 | $3M | Sell |
108,226
-314
| -0.3% | -$8.71K | 0.85% | 39 |
|
|
2023
Q4 | $3.12M | Sell |
108,540
-1,573
| -1% | -$47.6K | 0.95% | 36 |
|
|
2023
Q3 | $3.65M | Buy |
110,113
+205
| +0.2% | +$7.25K | 1.17% | 32 |
|
|
2023
Q2 | $4.03M | Buy |
109,908
+1,565
| +1% | +$60.9K | 1.22% | 31 |
|
|
2023
Q1 | $4.42M | Buy |
108,343
+250
| +0.2% | +$10.8K | 1.36% | 28 |
|
|
2022
Q4 | $5.54M | Sell |
108,093
-5,074
| -4% | -$243K | 1.7% | 19 |
|
|
2022
Q3 | $4.95M | Sell |
113,167
-1,917
| -2% | -$93.2K | 1.61% | 21 |
|
|
2022
Q2 | $6.03M | Sell |
115,084
-270
| -0.2% | -$13.8K | 1.8% | 20 |
|
|
2022
Q1 | $5.97M | Sell |
115,354
-450
| -0.4% | -$23.3K | 1.58% | 24 |
|
|
2021
Q4 | $6.84M | Sell |
115,804
-3,635
| -3% | -$180K | 1.75% | 22 |
|
|
2021
Q3 | $5.14M | Buy |
119,439
+632
| +0.5% | +$28K | 1.43% | 30 |
|
|
2021
Q2 | $4.65M | Sell |
118,807
-300
| -0.3% | -$11.7K | 1.33% | 29 |
|
|
2021
Q1 | $4.32M | Buy |
119,107
+4,340
| +4% | +$154K | 1.28% | 29 |
|
|
2020
Q4 | $4.22M | Sell |
114,767
-7,578
| -6% | -$278K | 1.33% | 29 |
|
|
2020
Q3 | $4.26M | Sell |
122,345
-754
| -0.6% | -$26.4K | 1.48% | 27 |
|
|
2020
Q2 | $3.82M | Sell |
123,099
-6,848
| -5% | -$233K | 1.4% | 28 |
|
|
2020
Q1 | $4.02M | Sell |
129,947
-565
| -0.4% | -$19.3K | 1.64% | 26 |
|
|
2019
Q4 | $4.85M | Buy |
130,512
+2,161
| +2% | +$77K | 1.58% | 27 |
|
|
2019
Q3 | $4.38M | Buy |
128,351
+3,928
| +3% | +$143K | 1.53% | 30 |
|
|
2019
Q2 | $5.11M | Buy |
124,423
+812
| +0.7% | +$32.2K | 1.83% | 21 |
|
|
2019
Q1 | $4.98M | Buy |
123,611
+1,709
| +1% | +$68.4K | 1.81% | 24 |
|
|
2018
Q4 | $5.05M | Sell |
121,902
-4,170
| -3% | -$173K | 2.04% | 20 |
|
|
2018
Q3 | $5.27M | Sell |
126,072
-5,291
| -4% | -$204K | 1.91% | 23 |
|
|
2018
Q2 | $4.52M | Sell |
131,363
-1,834
| -1% | -$62.7K | 1.73% | 24 |
|
|
2018
Q1 | $4.49M | Sell |
133,197
-106
| -0.1% | -$3.64K | 1.73% | 25 |
|
|
2017
Q4 | $4.58M | Sell |
133,303
-4,830
| -3% | -$165K | 1.7% | 25 |
|
|
2017
Q3 | $4.68M | Buy |
138,133
+4,374
| +3% | +$141K | 1.74% | 25 |
|
|
2017
Q2 | $4.26M | Buy |
133,759
+843
| +0.6% | +$26.6K | 1.61% | 27 |
|
|
2017
Q1 | $4.31M | Sell |
132,916
-330
| -0.2% | -$10.4K | 1.58% | 28 |
|
|
2016
Q4 | $4.11M | Sell |
133,246
-305
| -0.2% | -$9.31K | 1.53% | 28 |
|
|
2016
Q3 | $4.29M | Buy |
133,551
+263
| +0.2% | +$8.79K | 1.63% | 26 |
|
|
2016
Q2 | $4.45M | Sell |
133,288
-7,953
| -6% | -$254K | 1.66% | 26 |
|
|
2016
Q1 | $3.97M | Sell |
141,241
-7,169
| -5% | -$205K | 1.43% | 31 |
|
|
2015
Q4 | $4.54M | Sell |
148,410
-4,216
| -3% | -$133K | 1.74% | 25 |
|
|
2015
Q3 | $4.55M | Sell |
152,626
-3,911
| -2% | -$125K | 1.85% | 23 |
|
|
2015
Q2 | $4.98M | Sell |
156,537
-2,395
| -2% | -$78.1K | 1.9% | 19 |
|
|
2015
Q1 | $5.25M | Buy |
158,932
+88
| +0.1% | +$2.8K | 1.98% | 18 |
|
|
2014
Q4 | $4.69M | Buy |
158,844
+2,002
| +1% | +$57.4K | 1.78% | 23 |
|
|
2014
Q3 | $4.4M | Sell |
156,842
-701
| -0.4% | -$19.7K | 1.76% | 22 |
|
|
2014
Q2 | $4.44M | Buy |
157,543
+34
| +0% | +$969 | 1.71% | 25 |
|
|
2014
Q1 | $4.8M | Sell |
157,509
-1,792
| -1% | -$53.4K | 1.9% | 22 |
|
|
2013
Q4 | $4.63M | Sell |
159,301
-5,164
| -3% | -$150K | 1.82% | 22 |
|
|
2013
Q3 | $4.48M | Sell |
164,465
-774
| -0.5% | -$21.1K | 1.88% | 23 |
|
|
2013
Q2 | $4.39M | Buy |
+165,239
| New | +$4.57M | 1.89% | 20 |
|
Other funds holding PFE
AIM
SLAM
CWP
Monarch Capital Management's PFE Position: Q2 2026 in Review
Monarch Capital Management increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $71.4K and bringing the position to 127,572 shares worth $3.07M. The position accounts for 0.7% of the portfolio, ranked #43.
Monarch Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.84M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Monarch Capital Management held 127,572 shares of Pfizer worth $3.07M as of Q2 2026.
- Monarch Capital Management bought 2,730 Pfizer shares in Q2 2026, an estimated $71.4K.
- Pfizer made up 0.7% of Monarch Capital Management's portfolio in Q2 2026, its #43 holding.
- Monarch Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Monarch Capital Management's Pfizer position peaked at $6.84M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.